New hope for tough prostate cancer: RS-113 drug trial underway
Disease control
Ongoing
This study tests a new drug called RS-113 in 120 men with advanced prostate cancer that has spread and stopped responding to standard hormone therapy. The goal is to find the best dose that can slow or stop cancer growth, comparing it to an existing drug, abiraterone. Participant…
Phase: PHASE2 • Sponsor: R-Pharm International, LLC • Aim: Disease control
Last updated May 07, 2026 18:42 UTC